Cargando…

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

BACKGROUND: Inflammatory breast cancer (IBC), a particularly aggressive form of breast cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted therapies, the identification of molecular markers of IBC is of major importance. The heparan sulfate proteoglycan Syndecan-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Sherif Abdelaziz, Gadalla, Ramy, El-Ghonaimy, Eslam A., Samir, Omnia, Mohamed, Hossam Taha, Hassan, Hebatallah, Greve, Burkhard, El-Shinawi, Mohamed, Mohamed, Mona Mostafa, Götte, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341174/ https://www.ncbi.nlm.nih.gov/pubmed/28270211 http://dx.doi.org/10.1186/s12943-017-0621-z

Ejemplares similares

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients
por: Saleh, Moshira Ezzat, et al.
Publicado: (2019)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

Human Cytomegalovirus Infection Enhances NF-κB/p65 Signaling in Inflammatory Breast Cancer Patients
por: El-Shinawi, Mohamed, et al.
Publicado: (2013)

Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression()
por: Ibrahim, Sherif A., et al.
Publicado: (2016)

Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression
por: Mohamed, Hossam T., et al.
Publicado: (2018)

Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas
por: El-Nadi, Mennatullah, et al.
Publicado: (2020)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer
por: Ahmed, Sarah Hamdy, et al.
Publicado: (2021)

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
por: Ibrahim, Sherif A., et al.
Publicado: (2013)

Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value
por: Fahim, Sarah Atef, et al.
Publicado: (2020)

Inflammatory Breast Cancer: The Secretome of HCMV(+) Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers
por: Mohamed, Hossam Taha, et al.
Publicado: (2022)

The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity
por: Ibrahim, Aya Saber, et al.
Publicado: (2022)

The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
por: Hassan, Nourhan, et al.
Publicado: (2023)

Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells
por: Katakam, Sampath Kumar, et al.
Publicado: (2020)

Inflammatory Breast Cancer: High Incidence of Detection of Mixed Human Cytomegalovirus Genotypes Associated with Disease Pathogenesis
por: Mohamed, Hossam Taha, et al.
Publicado: (2014)

Infrared Microspectroscopy and Imaging Analysis of Inflammatory and Non-Inflammatory Breast Cancer Cells and Their GAG Secretome
por: Mohamed, Hossam Taha, et al.
Publicado: (2020)

Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
por: Wischmann, Franz-Josef, et al.
Publicado: (2023)

HS2ST1‐dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior
por: Vijaya Kumar, Archana, et al.
Publicado: (2020)

Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer
por: Onyeisi, Jessica Oyie Sousa, et al.
Publicado: (2021)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Syndecan-3 adds a Notch to its belt
por: Short, Ben
Publicado: (2010)

Syndecan-3 and Notch cooperate in regulating adult myogenesis
por: Pisconti, Addolorata, et al.
Publicado: (2010)

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells
por: Valla, Sofía, et al.
Publicado: (2021)

Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
por: Wang, X, et al.
Publicado: (2014)

Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer
por: Hosney, Mohamed, et al.
Publicado: (2017)

Inflammatory breast cancer: New factors contribute to disease etiology: A review
por: Mohamed, Mona M., et al.
Publicado: (2014)

Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023)

The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis
por: Timmen, Melanie, et al.
Publicado: (2020)

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

Detection of Micro-invasion in Sudanese Oral Verrucous Carcinoma Samples Using Syndecan-1 Stain
por: Elhassan, AKB, et al.
Publicado: (2019)

Assessing awareness and attitude of Egyptian medical students towards emergency medicine as a specialty and career choice: A single-institutional study
por: Hussein, Mohamed A, et al.
Publicado: (2023)

Impact of implementation of sequential trauma education programs (STEPs) course on missed injuries in emergency polytrauma patients, Ismailia, Egypt
por: Elbaih, Adel Hamed, et al.
Publicado: (2022)

Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression
por: Beauvais, DeannaLee M., et al.
Publicado: (2022)

Relevance of Serum Levels of Interleukin-6 and Syndecan-1 in Patients with Hepatocellular Carcinoma
por: Metwaly, Heba A., et al.
Publicado: (2012)

Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohort
por: Aboelhassan, Rasha, et al.
Publicado: (2023)

Cathepsin b: a potential prognostic marker for inflammatory breast cancer
por: Nouh, Mohamed A, et al.
Publicado: (2011)

Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers
por: Tarek, Alshaimaa, et al.
Publicado: (2022)

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion
por: Masoud, Hossam Hosny, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0v4uekeog3p1dqsf3gfqkqj5j